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ABSTRACT
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general 
population. Many cardiovascular diseases and concomitant conditions increase the risk of 
the development of AF, recurrent AF, and AF-associated complications. Knowledge of these 
factors and their management is hence important for the optimal management of patients 
with AF. Recent studies have suggested that lowering the blood pressure threshold can 
improve the patients' outcome. Moreover, adverse events associated with a longer duration 
of hypertension can be prevented through strict blood pressure control. Pre-hypertension, 
impaired fasting glucose, abdominal obesity, weight fluctuation, and exposure to air 
pollution are related to the development of AF. Finally, female sex is not a risk factor of 
stroke, and the age threshold for stroke prevention should be lowered in Asian populations. 
The management of diseases related to AF should be provided continuously, whereas lifestyle 
factors should be monitored in an integrated manner.
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INTRODUCTION
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general 
population.1-3) AF increases the risk of mortality and morbidity resulting from stroke, 
congestive heart failure, dementia, and impaired quality of life, which explains its enormous 
socioeconomic and healthcare implications.3)4) The prevalence of AF progressively increased 
by 2.10-fold from 0.73% in 2006 to 1.53% in 2015 in Korea. The prevalence of AF in the 
Korean population is expected to reach 5.81% (2,290,591 patients with AF) by 2060.3)
The incidence of AF has been shown to be positively correlated with age, male sex, diabetes, 
hypertension, congestive heart failure, valve disease, and myocardial infarction (MI).3)5)6) 
The management of risk factors or comorbidities, including lifestyle factors, is an important 
component of an integrated AF management.3)7) An integrated approach to AF management 
is the basis of consistent guideline-based treatment of AF, and such guideline adherence 
helps improve patient outcomes.
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HYPERTENSION
Hypertension is highly prevalent in the adult population with AF, especially among persons 
older than 60 years, and affects approximately 1 billion adults worldwide.1)2)8) According to 
the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation 
and Treatment of High Blood Pressure guidelines, 62.2% of Korean patients with AF had 
hypertension.9) After applying the 2017 American College of Cardiology/American Heart 
Association guidelines for hypertension, 79.4% had hypertension, adding 17.2% cases 
as newly re-defined hypertension (130–139/80–89 mmHg). The Korean population with 
hypertension (hazard ratio [HR], 1.80; 95% confidence interval [CI], 1.62–1.99; p<0.001) 
had an increased risk of new-onset AF (Table 1).5) Hypertension and pre-hypertension are 
independently associated with AF.10)11) Indeed, AF can be considered a manifestation of target 
organ damage due to hypertension.
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Risk Factors of AF
Table 1. Baseline characteristics and risk of atrial fibrillation
Characteristics Number (n=171,324) HR* (95% CI) p value
Sex
Female 67,142 1
Male 104,182 1.65 (1.49–1.82) <0.001
Age (years)
40–49 100,269 1
50–59 47,917 1.67 (1.49–1.87) <0.001
60–69 19,215 3.60 (3.19–4.07) <0.001
70–79 3,923 5.04 (4.18–6.06) <0.001
BMI (kg/m2)
<18.5 3,141 1.10 (0.87–1.39) 0.97
18.5–19.9 9,322 1.06 (0.84–1.35) 0.93
20.0–22.4 41,575 1
22.5–24.9 59,984 1.03 (0.91–1.17) 0.60
≥25.0 57,302 1.24 (1.10–1.41) <0.001
Hypertension
No 113,929 1
Yes 57,395 1.80 (1.62–1.99) <0.001
DM
No 156,609 1
Yes 14,715 0.95 (0.83–1.10) 0.53
Dyslipidemia
No 123,995 1
Yes 47,329 1.12 (1.02–1.24) 0.01
MI
No 169,470 1
Yes 1,584 1.60 (1.17–2.18) <0.003
Excessive alcohol intake (≥5 times/week)
No 165,296 1
Yes 6,028 0.99 (0.80–1.22) 0.99
Excessive exercise (≥5 times/week)
No 160,315 1
Yes 11,009 0.95 (0.80–1.12) 0.55
Heavy smoking (≥30 pack-years)
No 153,404 1
Yes 19,374 1.10 (0.96–1.26) 0.13
BMI = body mass index; CI = confidence interval; DM = diabetes mellitus; HR = hazard ratio; MI = myocardial infarction.
*HRs were adjusted for clinical variables including age, sex, initial BMI, hypertension, diabetes mellitus, 
dyslipidemia, excessive alcohol intake (drinking ≥5 times/week), excessive exercise (exercise ≥5 times/week), and 
heavy smoking (smoking ≥30 pack-years).
What is the ideal blood pressure treatment threshold for atrial fibrillation?
The presence of hypertension in patients with AF has been identified to be an independent 
risk factor for stroke, increasing the risk by 1.8- to 2-fold compared with that in the absence 
of hypertension. Uncontrolled high blood pressure enhances the risk of stroke and bleeding 
events and may lead to recurrent AF.12) Therefore, good blood pressure control should form 
an integral part of the management of patients with AF, as a component of the holistic 
approach to AF management.7) However, the optimal blood pressure treatment threshold for 
patients with AF with hypertension has not been well identified.
Two recent studies suggested that blood pressure should be more strictly controlled in 
patients with AF.9)11) Patients with newly re-defined hypertension had a greater risk of major 
cardiovascular events (HR, 1.07; 95% CI, 1.05–1.10), ischemic stroke (HR, 1.12; 95% CI, 1.08–
1.16), intracranial hemorrhage (HR, 1.12; 95% CI, 1.01–1.23), and admission for heart failure 
(HR, 1.06; 95% CI, 1.01–1.11) than non-hypertensive patients (<130/80 mmHg).9) In patients 
with AF under hypertension treatment, a U-shaped relationship for major cardiovascular 
events was evident, with 120–129/<80 mmHg as the optimal blood pressure treatment target 
(Figure 1). The benefit-to-harm ratio of optimal blood pressure control (120–129/<80 mmHg) 
relative to suboptimal blood pressure control (130–139/80–89 mmHg) was >1.00 for all 
subgroups stratified by the 10-year cardiovascular disease risk (<10%, 10–20%, and >20%), 
suggesting that patients with AF with treated hypertension would have greater benefit than 
harm from optimal blood pressure control regardless of the estimated cardiovascular disease 
risk (Figure 2).9)
Effect of hypertension duration on ischemic stroke risk in atrial fibrillation
The increase of hypertension duration was associated with an increased risk of ischemic 
stroke. A 1-year increase of hypertension duration continuously increased the adjusted risk 
of ischemic stroke until 7 years and reached a plateau with an adjusted HR of 1.6. The risk of 
ischemic stroke linearly increased with the increase of hypertension duration in patients aged 
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Figure 1. Risk of adverse outcomes according to blood pressure. 
CI = confidence interval; HR = hazard ratio.
<65 years, whereas the risk reached a plateau in those aged ≥65 years (Figure 3). In all baseline 
and pre-AF average systolic blood pressure subgroups, a longer duration of hypertension 
before AF was associated with a higher ischemic stroke risk than a shorter duration of 
hypertension.13) However, this long-term effect of hypertension duration can be attenuated 
by long-term strict systolic blood pressure control throughout the entire duration of 
hypertension. The effect of long-term hypertension was not observed in patients with strictly 
well-controlled pre-AF average systolic blood pressure of <120 mmHg (Figure 4).13)
DIABETES
Diabetes and AF frequently coexist because of their associations with other risk factors. 
Diabetes is a risk factor for stroke and other complications in AF.2)14) In patients with AF, 
a longer duration of diabetes seems to confer a higher risk of thrombo-embolism, albeit 
without a greater risk of oral anticoagulant (OAC)-related bleeding.15)
An impaired fasting glucose (IFG) is a prior stage to diabetes, which is a well-known risk 
factor for AF. Because IFG is common worldwide and is considered clinically normal, 
treatments for this condition are rare. Lee et al.11) reported that in healthy Asian populations 
without comorbidities, IFG and pre-hypertension were important risk factors for AF. 
Subjects with IFG (HR, 1.16) had a higher risk of AF, and diastolic blood pressure (HR, 1.11) 
was a stronger indicator for the occurrence of AF than systolic blood pressure. As the risks 
IFG, pre-hypertension, and body mass index (BMI) ≥25 kg/m2 increased, the risk of AF also 
increased. Even in a healthy population, subjects with all 3 risks had a much higher AF risk 
(HR, 1.50) than those without. IFG related to AF was more prominent in subjects with BMI 
<25 kg/m2 (HR, 1.18) than in those with BMI ≥25 kg/m2, and subjects with both IFG and 
pre-hypertension had a greater AF risk (HR, 1.27) than those without (Figure 5).11) The BMI-
dependent effects of pre-hypertension and IFG also showed a similar pattern for AF-related 
stroke, HF, and mortality in a healthy population.11)
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Figure 2. Benefit-to-harm ratios of optimal (120–129/<80 mmHg) versus suboptimal blood pressure control 
(130–139/80–89 mmHg) according to 10-year predicted cardiovascular risk subgroups. 
AF = atrial fibrillation; CVD = cardiovascular disease. 
*If a p value is less than 0.05, it is flagged with one star.
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Figure 3. Duration of hypertension and risk of ischemic stroke in patients with AF according to different age categories. (A) Age <55 years. (B) Age 55–64 years. 
(C) Age 65–74 years. (D) Age ≥75 years. Patients with hypertension duration under 1 year are used as reference. 
AF = atrial fibrillation; CI = confidence interval; HR = hazard ratio.
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Figure 4. Risk of ischemic stroke according to the duration of hypertension in patients with AF. (A) Baseline SBP <120 mmHg. (B) Baseline SBP 120–139 mmHg. 
AF = atrial fibrillation; CI = confidence interval; HR = hazard ratio; HTN = hypertension; SBP = systolic blood pressure.
OBESITY
Obesity is linked to AF and is considered a conventional risk factor for adverse cardiovascular 
events.16-19) Large epidemiological studies have observed strong associations between obesity 
and the incidence of AF and AF-related complications.16-19) Obesity is associated with an 
increased left atrial size and a decreased left ventricular diastolic function, which, in turn, 
leads to an increased left atrial pressure.18) In addition, dynamic changes in left atrial size 
and pressure likely affect both the atrial substrate and the triggers for AF.17) In the Korean 
population, a high BMI (≥25 kg/m2; HR, 1.24; 95% CI, 1.10–1.41) was associated with a greater 
AF risk compared with a BMI of 20–22.5 kg/m2 (Table 1).5)
Waist circumference and waist-to-hip circumference ratio are also associated with a higher 
risk of AF.20) Visceral adiposity is associated with incident cardiovascular disease after 
adjustment for clinical risk factors and generalized adiposity.21) The prevalence of overweight 
and obesity is much lower in Asian populations than in Western populations.1)19)
Baek et al.19) showed that abdominal obesity is an important, potentially modifiable risk 
factor for AF in non-obese Asians. After multivariable adjustment, each 1 standard deviation 
(3.7 kg/m2 and 9.4 cm) increase in BMI or waist circumference was associated with an 
increase of 8% (p<0.001) and 12% (p<0.001), respectively. Spline curves between BMI 
and waist circumference, and the HR of new-onset AF are presented in Figure 6. A non-
linear J-shaped association was found between continuous BMI variables and AF risk. AF 
risk positively increased with the increase of waist circumference. Interestingly, the overall 
J-shaped and linear patterns in the association seem to be mainly driven by the patterns for 
men. Abdominal obesity was associated with new-onset AF in the underweight (p<0.001), 
normal (p<0.001), and overweight (p<0.001) groups, but not in the obese group (p=0.894). 
These data suggest that interventions to decrease abdominal obesity may reduce the 
population burden of AF.19)
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No risk factor (Ref=1) No. %
Single factor 77,801 34.3
Pre-HTN 69,627 30.7
HR LCL UCL
1.11 0.96 1.28
IFG 11,773 5.2 1.21 0.96 1.54
BMI≥25 kg/m2 13,176 5.8 1.51 1.21 1.88
Combined factors
Pre-HTN+IFG 16,261 7.2 1.27 1.05 1.54
Pre-HTN+BMI≥25 kg/m2 26,171 11.5 1.45 1.22 1.72
IFG+BMI≥25 kg/m2 3,413 1.5 1.62 1.15 2.29
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Figure 5. Incidence and risk of AF based on the combination of risk factors. 
AF = atrial fibrillation; BMI = body mass index; HR = hazard ratio; HTN = hypertension; LCL = lower confidence 
limit; IFG = impaired fasting glucose; UCL = upper confidence limit.
WEIGHT FLUCTUATION
The use of baseline weight or BMI measurements alone cannot capture the dynamic BMI 
changes that may inﬂuence the incidence of AF.17) Patients in the normal or underweight 
BMI category may experience undesired weight loss due to other medical problems, which 
may affect the incidence of AF in the general population.22) The Atherosclerosis Risk in 
Communities study found that a weight loss or gain of >5% of the initial body weight 
was positively associated with AF.22) In addition, the LEGACY study reported incremental 
increases in AF burden with weight fluctuations.23)
In the underweight and normal Asian population, BMI variability, especially weight gain, 
increased the risk of incident AF and MI but not the risk of stroke.5) Figure 7 shows the 
incidence of new-onset AF, MI, ischemic stroke, and cardiovascular death per 1,000 person-
years according to BMI variability. In initially underweight and normal individuals (initial 
BMI <25 kg/m2), the highest BMI variability (Q4) was associated with a significantly higher 
incidence of AF than a stable BMI variability (Q1). Furthermore, the highest BMI variability, 
especially weight gain, was related to higher systolic and diastolic blood pressure, fasting 
blood glucose level, and total cholesterol level than those with a more stable BMI variability. 
The Korean population with dyslipidemia (HR, 1.12; 95% CI, 1.02–1.24; p=0.01) had an 
increased risk of new-onset AF (Table 1).5) This finding suggests that avoiding weight 
fluctuation, especially weight gain, is important to prevent AF and to decrease the risk of MI 
in the underweight and normal Asian populations.5)
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Figure 6. Spline curves between BMI and WC, and the HR of new-onset AF. Although there was a non-linear J-shaped association between continuous BMI 
variables and AF risk (A), the AF risk increased positively as WC increased (B). 
AF = atrial fibrillation; BMI = body mass index; HR = hazard ratio; WC = waist circumference.
MYOCARDIAL INFARCTION
AF is a common arrhythmia of acute MI (AMI) that has been shown to be related to 
increased in-hospital and long-term mortality rates.24) Various pathologic mechanisms 
including elevated left ventricular end-diastolic pressure, increased atrial pressures, acute 
deterioration of left ventricular function, left atrial enlargement, atrial ischemia, or infarction 
can contribute to the development of AF in the AMI setting.24) Inflammatory markers, 
mainly C-reactive protein, have been reported to be related to future AF development.25)26) 
Accordingly, Hwang et al.27) reported that C-reactive protein could be strongly related to early 
AF in patients with AMI, especially in those with a less dilated left atrium.
In addition to being an established complicating factor for MI, recent studies have revealed 
that AF increased the risk of MI.28) Lee et al.29) reported that AF was associated with a 3-fold 
increased risk of MI (HR, 3.1; 95% CI, 2.22–4.37) in both men (HR, 2.91; 95% CI, 1.91–4.45) 
and women (HR, 3.52; 95% CI, 2.01–6.17) (Figure 8). The risk of AF-associated MI was higher 
in patients free of hypertension, diabetes, ischemic stroke, and dyslipidemia at baseline. The 
cumulative incidence of AF-associated MI was lower in patients under anticoagulant and 
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Figure 7. Incidence rate according to BMI variability. New-onset AF (A), MI (B), ischemic stroke (C), and cardiovascular death (D). Q1: ASV<0.5; Q2: 0.5≤ASV<1.0; 
Q3: 1.0≤ASV<1.5; Q4: ASV≥1.5. 
AF = atrial fibrillation; ASV = average successive variability; BMI = body mass index; MI = myocardial infarction. 
*Asterisks indicate that there is a significant difference between overall Q1 and Q4 (p<0.05).
statin treatments. This finding suggests that that AF complications beyond stroke should 
extend to total mortality to include MI.29)
AIR POLLUTION
Epidemiological studies have suggested that exposure to elevated levels of ambient 
particulate matter (PM) <2.5 μm (PM2.5) or <10 μm (PM10) in aerodynamic diameter is 
consistently associated with adverse cardiac events.30-33) Although many studies for these 
adverse cardiovascular outcomes have been performed, the correlations between short-term 
exposures to PM2.5 and incident AF were uncertain.34) However, these studies were performed 
in the European countries and United States, where the air pollution levels are much lower 
than in Asian countries. Therefore, the effect sizes could be low in those studies.
Kim et al.35) reported that long-term exposure to PM2.5 (HR 1.18 for 10 μg/m3 increments, 
p<0.001) and PM10 (HR 1.03 for 10 μg/m3 increments, p<0.001) is associated with an 
increased incidence of new-onset AF in the Asian general population (Figure 9). It is 
more profound in obese male subjects older than 60 years and in those with a history of 
hypertension or previous MI.35)
PREDICTION OF STROKE RISK
Stroke prevention is the principal management priority in patients with AF, given its 
association with a 5-fold increase in stroke risk.3)15)36) The CHA2DS2-VASc score is now used 
in most guidelines for stroke prevention in patients with AF.3)15) The adjusted incidence rates 
(per 100 person-years) of ischemic stroke were 3.79 in Korea, being 0.26 in low-risk patients 
(CHA2DS2-VASc score 0 [men] or 1 [female]), 1.18 in intermediate-risk patients (CHA2DS2-
VASc score 1 [men]), and 5.30 in high-risk patients (CHA2DS2-VASc ≥2).2) The more recent 
focus of stroke prevention in patients with non-valvular AF has shifted away from predicting 
“high-risk” patients toward initially identifying patients at a “truly low-risk” of ischemic 
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Figure 8. AF and MI. (A) Cumulative incidence of MI related to AF in the propensity scored-matched cohort. (B) Age-adjusted incidence rate and incidence rate 
ratios of MI. 
AF = atrial fibrillation; MI = myocardial infarction. 
*If a p value is less than 0.05, it is flagged with one star.
stroke in whom OAC has no net clinical benefit.8) Korean patients who were categorized as 
“low-risk” by the CHA2DS2-VASc score (i.e., score of 0 point in men or 1 point in female) 
consistently had an event rate of <1%/year.2)
Stroke risk as assessed by the CHA2DS2-VASc score is dynamic and changes over time. The 
rates of ischemic stroke increased when patients accumulated risk factors and were re-
classified into higher CHA2DS2-VASc score categories. Assessment of stroke risk is needed at 
every patient contact, as accumulation of risk factors with increasing CHA2DS2-VASc score 
translates to greater stroke risks over time (Figure 10).14)
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Figure 9. Concentration-response relationships between incident AF and long-term exposures to air pollution. (A) PM2.5. (B) PM10. 
AF = atrial fibrillation; HR = hazard ratio; PM2.5 = particulate matter <2.5 μm; PM10 = particulate matter <10 μm.
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Figure 10. ROC curves of delta CHA2DS2-VASc scores in predicting ischemic stroke. 
AUC = area under the curve; CI = confidence interval; ROC = receiver operating characteristic; SE = standard error.
Female sex
In Koreans, the risk of incident AF was higher in men than in women (HR, 1.65; 95% CI, 
1.49–1.82) (Table 1).5) On multivariable analysis, significant associations between CHA2DS2-
VASc risk factors and ischemic stroke were observed; however, the significance of vascular 
disease or diabetes mellitus was attenuated after multivariable adjustment, and female sex 
(HR, 0.73; 95% CI, 0.64–0.84) had a lower risk of ischemic stroke than male sex (Table 2).2)37) 
Several cohort studies have shown that female sex is a risk factor for stroke, albeit dependent 
on age.38)39) Recently, female sex was suggested as a risk modifier for stroke in patients with 
AF.40) However, Asian cohort studies have indicated that female sex was not an independent 
risk factor for ischemic stroke, again suggesting some potential ethnic differences in the risk 
of stroke between Asian and non-Asian populations.3) Consistent with previous Asian studies, 
female sex was not a risk factor for stroke in a Korean cohort; instead, it was associated with a 
lower stroke risk of ischemic stroke than that of male sex.2)37)
Age threshold
The risk of incident AF was increased with advancing age (Table 1).5) Older age is also the 
most important risk factor for ischemic stroke in AF among the 7 individual risk factors 
included in the CHA2DS2-VASc score, particularly for low- to intermediate-risk patients.41-43) 
However, the appropriate age threshold (e.g., CHA2DS2-VASc score, 1 point for age 65–74 
years, 2 points for age ≥75 years) is still controversial, as actual age thresholds may differ 
between different countries and ethnic groups. Moreover, the ability of a risk scoring scheme 
to identify patients with AF who are at a “truly low-risk” of stroke is even more important 
in Asians because the stroke risk among Asian populations may be much higher than that 
among Western populations.44-47)
Older age is the most important predictor of ischemic stroke in Korean and Taiwan patients 
with AF.43)48) Patients aged 65–74 years without other risk factors showed a significantly higher 
risk of stroke than those with 1 risk factor other than age. Lowering the current age threshold 
(age ≥65 years) in the CHA2DS2-VASc score to age ≥55 years might be appropriate in Asian 
patients with AF.43)
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Table 2. Associations between baseline factors and ischemic stroke in patients without anticoagulant treatment4) 
Characteristics
Ischemic stroke
Number with event Univariable Multivariable
HR 95% CI HR 95% CI
Age (years)
<65 161/2,594 Ref. Ref.
65–74 320/1,700 3.44 2.84–4.16 2.11 1.73–2.58
>75 338/1,561 4.70 3.90–5.68 3.11 2.51–3.85
Female sex 385/2,835 0.94 0.82–1.07 0.75 0.63–0.86
Ischemic stroke/TIA 411/1,433 3.81 3.32–4.37 2.58 2.23–2.97
Atherosclerotic disease
MI 139/764 1.49 1.24–1.79 0.97 0.81–1.17
Peripheral arterial disease 113/611 1.45 1.19–1.76 0.95 0.78–1.17
Vascular disease* 221/1,206 1.54 1.32–1.80 0.98 0.84–1.15
HF 380/1,869 2.16 1.88–2.48 1.23 1.06–1.42
Hypertension 750/4,422 4.04 3.16–5.17 1.85 1.43–2.40
Diabetes 216/1,168 1.53 1.31–1.79 1.13 0.96–1.32
ESRD 23/89 2.36 1.56–3.57 2.03 1.33–3.09
COPD 134/673 1.72 1.43–2.07 1.13 0.94–1.37
Aspirin use 505/2,636 1.93 1.68–2.23 1.30 1.12–1.50
CI = confidence interval; COPD = chronic obstructive pulmonary disease; ESRD = end-stage renal disease; HF = heart failure; HR = hazard ratio; MI = myocardial 
infarction; TIA = transient ischemic attack.
*Vascular disease includes previous MI, peripheral arterial disease, or aortic plaque.
CONCLUSION
The management of diseases (obesity, hypertension, heart failure, diabetes mellitus, sleep apnea) 
related to AF should be provided continuously, whereas lifestyle factors such as smoking and 
drinking should be monitored in an integrated manner.3) However, in lean Asian populations, 
strict blood pressure control and management of IFG should be emphasized. Avoiding abdominal 
obesity and weight fluctuation, as well as controlling the exposure to air pollution might reduce 
the development of AF. Finally, female sex is not a risk factor for stroke in Asian populations. 
Lowering the current age threshold (age ≥65 years) in the CHA2DS2-VASc score to age ≥55 
years might be appropriate in Asian patients with AF. Knowledge of these factors and their 
management will enable optimal management and can improve the outcome of patients with AF.
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